Robert Allnutt - Net Worth and Insider Trading

Robert Allnutt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Allnutt owns 1 companies in total, including RespireRx Pharmaceuticals Inc (RSPI) .

Click here to see the complete history of Robert Allnutt’s form 4 insider trades.

Insider Ownership Summary of Robert Allnutt

Ticker Comapny Transaction Date Type of Owner
RSPI RespireRx Pharmaceuticals Inc 2003-12-09 director

Robert Allnutt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Allnutt Ownership Network

Ownership Network List of Robert Allnutt

No Data

Ownership Network Relation of Robert Allnutt

Insider Network Chart

Robert Allnutt Owned Company Details

What does RespireRx Pharmaceuticals Inc do?

Who are the key executives at RespireRx Pharmaceuticals Inc?

Robert Allnutt is the director of RespireRx Pharmaceuticals Inc. Other key executives at RespireRx Pharmaceuticals Inc include SVP of Pre-Clinical Prod. Dev. David Dickason , director & CEO and President Timothy L. Jones , and director & President & CEO Manuso James S J .

RespireRx Pharmaceuticals Inc (RSPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of RespireRx Pharmaceuticals Inc (RSPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RespireRx Pharmaceuticals Inc (RSPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

RespireRx Pharmaceuticals Inc (RSPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RespireRx Pharmaceuticals Inc Insider Transactions

No Available Data

Robert Allnutt Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Allnutt. You might contact Robert Allnutt via mailing address: 3260 Whippie Road, Union City Ca 94587.

Discussions on Robert Allnutt

No discussions yet.